| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $45.59 | $1,806,892.70 | -0.3% | |
| Mar 21, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $50.95 | $2,019,619.96 | -0.3% | |
| Mar 15, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $52.34 | $52,339.00 | -1.7% | |
| Mar 15, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $52.44 | $209,764.00 | -8.9% | |
| Mar 15, 2018 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 42,026 | $52.85 | $2,220,869.54 | -6.8% | |
| Mar 14, 2018 | Yu K Peony | Chief Medical Officer | Sell | 9,891 | $53.20 | $526,201.20 | -7.2% | |
| Mar 13, 2018 | Tamura Toshinari | Director | Sale+OE | 24,000 | $53.37 | $1,280,897.88 | -18.5% | |
| Mar 13, 2018 | Riggs Rory B67 | Director | Sell | 32,095 | $54.66 | $1,754,464.50 | -2.0% | |
| Mar 12, 2018 | Kearns Thomas F Jr | Director | Sale+OE | 18,000 | $55.00 | $990,000.00 | -11.8% | |
| Mar 9, 2018 | Riggs Rory B67 | Director | Sell | 22,905 | $55.75 | $1,276,953.75 | -5.3% |